Paul Hebert · President, Canadian Institutes of Health Research (CIHR)
Advancing Canada’s health research and innovation agenda as it relates to funding, policy and program design, and regulatory matters, including in the areas of clinical trials and development of innovative medical treatments.Read more
Federal role in the health system as it relates to funding, the use of federal spending power, and pan-Canadian priorities, including in the areas of aging, older adult care, child and youth health, mental health and substance use, palliative care, Indigenous health, public health, and data.Read more
Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Benoit Leduc · Manager, Innovation, Science and Economic Development Canada (ISED)
Advancing Canada’s health research and innovation agenda as it relates to funding, policy and program design, and regulatory matters, including in the areas of clinical trials and development of innovative medical treatments.Read more
Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Paul Moen · Chief of Staff to the Minister of Industry, Innovation, Science and Economic Development Canada (ISED)
Advancing Canada’s health research and innovation agenda as it relates to funding, policy and program design, and regulatory matters, including in the areas of clinical trials and development of innovative medical treatments.Read more
Shalene Curtis-Micallef · Deputy Minister, Health Canada (HC)
Jocelyne Voisin · Senior Assistant Deputy Minister, Health Canada (HC)
Federal role in the health system as it relates to funding, the use of federal spending power, and pan-Canadian priorities, including in the areas of aging, older adult care, child and youth health, mental health and substance use, palliative care, Indigenous health, public health, and data.Read more
Strengthening Canada’s health workforce including promoting health workforce safety.
Improving Canada’s physical and digital infrastructure for both health research and healthcare delivery.
Advancing Canada’s health research and innovation agenda as it relates to funding, policy and program design, and regulatory matters, including in the areas of clinical trials and development of innovative medical treatments.
Jeff Moore · Associate Vice-President, Canadian Institutes of Health Research (CIHR)
Advancing Canada’s health research and innovation agenda as it relates to funding, policy and program design, and regulatory matters, including in the areas of clinical trials and development of innovative medical treatments.Read more
Paul Hebert · President, Canadian Institutes of Health Research (CIHR)
Advancing Canada’s health research and innovation agenda as it relates to funding, policy and program design, and regulatory matters, including in the areas of clinical trials and development of innovative medical treatments.Read more
Elizabeth Toller · Director General, Health Canada (HC)
Federal role in the health system as it relates to funding, the use of federal spending power, and pan-Canadian priorities, including in the areas of aging, older adult care, child and youth health, mental health and substance use, palliative care, Indigenous health, public health, and data.Read more
Paul Hebert · President, Canadian Institutes of Health Research (CIHR)
Advancing Canada’s health research and innovation agenda as it relates to funding, policy and program design, and regulatory matters, including in the areas of clinical trials and development of innovative medical treatments.Read more
Megan Bettle · Executive Director, Canadian Institutes of Health Research (CIHR)
Advancing Canada’s health research and innovation agenda as it relates to funding, policy and program design, and regulatory matters, including in the areas of clinical trials and development of innovative medical treatments.Read more
Paul Hebert · President, Canadian Institutes of Health Research (CIHR)
Nipun Vats · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Marcel Turcot · Vice-President of Strategic, Corporate and Public Affairs, Natural Sciences and Engineering Research Council (NSERC)
and 6 moreShow fewer
Valérie Laflamme · Associate Vice-President, Social Sciences and Humanities Research Council (SSHRC)
Sylvain Charbonneau · President and CEO, Innovation, Science and Economic Development Canada (ISED)
Ted Hewitt · President, Social Sciences and Humanities Research Council (SSHRC)
Alejandro Adem · President, Natural Sciences and Engineering Research Council (NSERC)
Jeff Moore · Associate Vice-President, Canadian Institutes of Health Research (CIHR)
Jocelyne Voisin · Senior Assistant Deputy Minister, Health Canada (HC)
Advancing Canada’s health research and innovation agenda as it relates to funding, policy and program design, and regulatory matters, including in the areas of clinical trials and development of innovative medical treatments.Read more
Paul Hebert · President, Canadian Institutes of Health Research (CIHR)
David Marchand · Director General, Canadian Institutes of Health Research (CIHR)
Advancing Canada’s health research and innovation agenda as it relates to funding, policy and program design, and regulatory matters, including in the areas of clinical trials and development of innovative medical treatments.Read more
Sandenga Yeba · Director of Policy and Deputy Chief of Staff, Health Canada (HC)
Advancing Canada’s health research and innovation agenda as it relates to funding, policy and program design, and regulatory matters, including in the areas of clinical trials and development of innovative medical treatments.Read more
Improving Canada’s physical and digital infrastructure for both health research and healthcare delivery.
Advancing Canada’s health research and innovation agenda as it relates to funding, policy and program design, and regulatory matters, including in the areas of clinical trials and development of innovative medical treatments.Read more
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026.
Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month.
Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means.
Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence.
PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.